Ronna Sue Cohen boosted its position in shares of Metlife Inc (NYSE:MET) by 4,021.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,686,512 shares of the financial services provider’s stock after purchasing an additional 2,621,329 shares during the period. Metlife accounts for 1.8% of Ronna Sue Cohen’s investment portfolio, making the stock its 26th biggest holding. Ronna Sue Cohen’s holdings in Metlife were worth $2,687,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Livingston Group Asset Management CO operating as Southport Capital Management purchased a new position in Metlife during the 1st quarter worth approximately $202,000. Northpointe Capital LLC acquired a new position in Metlife during the 1st quarter worth $5,104,000. Cohen Klingenstein LLC lifted its position in Metlife by 702.7% during the 1st quarter. Cohen Klingenstein LLC now owns 64,213 shares of the financial services provider’s stock worth $2,734,000 after acquiring an additional 56,213 shares during the last quarter. Pratt Collard Advisory Partners LLC lifted its position in Metlife by 44.0% during the 1st quarter. Pratt Collard Advisory Partners LLC now owns 25,435 shares of the financial services provider’s stock worth $1,083,000 after acquiring an additional 7,775 shares during the last quarter. Finally, Jolley Asset Management LLC lifted its position in Metlife by 4.5% during the 1st quarter. Jolley Asset Management LLC now owns 92,565 shares of the financial services provider’s stock worth $3,940,000 after acquiring an additional 3,953 shares during the last quarter. Hedge funds and other institutional investors own 76.88% of the company’s stock.

A number of research analysts have weighed in on MET shares. Sandler O’Neill raised shares of Metlife from a “hold” rating to a “buy” rating in a research report on Wednesday, January 2nd. Wells Fargo & Co reissued a “buy” rating on shares of Metlife in a research report on Tuesday, January 8th. Bank of America upgraded shares of Metlife from a “neutral” rating to a “buy” rating and set a $44.06 price objective on the stock in a report on Wednesday, January 16th. ValuEngine upgraded shares of Metlife from a “sell” rating to a “hold” rating in a report on Wednesday, January 16th. Finally, Zacks Investment Research downgraded shares of Metlife from a “buy” rating to a “hold” rating in a report on Monday, January 21st. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and six have issued a buy rating to the company. Metlife has an average rating of “Hold” and a consensus target price of $52.76.

In related news, CFO John D. Mccallion sold 2,669 shares of the company’s stock in a transaction dated Tuesday, February 12th. The shares were sold at an average price of $44.43, for a total value of $118,583.67. Following the sale, the chief financial officer now owns 20,538 shares of the company’s stock, valued at $912,503.34. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Steven J. Goulart sold 10,292 shares of the company’s stock in a transaction dated Tuesday, February 12th. The shares were sold at an average price of $44.40, for a total transaction of $456,964.80. Following the completion of the sale, the executive vice president now directly owns 93,214 shares in the company, valued at approximately $4,138,701.60. The disclosure for this sale can be found here. Insiders own 0.34% of the company’s stock.

Shares of NYSE:MET traded down $0.53 on Wednesday, hitting $45.66. 222,595 shares of the company were exchanged, compared to its average volume of 5,093,693. Metlife Inc has a one year low of $37.76 and a one year high of $48.92. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.14 and a current ratio of 0.14. The company has a market cap of $44.22 billion, a price-to-earnings ratio of 8.46, a PEG ratio of 0.98 and a beta of 1.18.

Metlife (NYSE:MET) last posted its quarterly earnings data on Wednesday, February 6th. The financial services provider reported $1.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.05. Metlife had a net margin of 7.53% and a return on equity of 10.24%. The company had revenue of $15.40 billion for the quarter, compared to the consensus estimate of $15.84 billion. During the same quarter in the previous year, the firm posted $0.64 EPS. The business’s revenue was up .0% compared to the same quarter last year. Equities analysts predict that Metlife Inc will post 5.48 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This news story was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2019/04/17/metlife-inc-met-shares-bought-by-ronna-sue-cohen.html.

Metlife Company Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Recommended Story: How Do You Make Money With Penny Stocks?

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.